International Psoriasis Council

Craig L. Leonardi, MD, FAAD

Craig L. Leonardi, MD, is Associate Clinical Professor of Dermatology at St. Louis University Medical School in St. Louis, Missouri, where he also has a private practice, Central Dermatology. He received his medical degree from the University of Miami School of Medicine in Miami, Florida, and completed an internship in pediatrics and residency in dermatology at the University of Miami/Jackson Memorial Hospital. Dr. Leonardi is certified by the American Board of Dermatology. He is a Fellow of the American Academy of Dermatology and a member of the Noah Worcester Dermatological Society. He serves as a member of the Medical Advisory Board of the National Psoriasis Foundation. Dr. Leonardi has extensive experience using the new biologics in the treatment of psoriasis. He has been an invited speaker at national, regional, and state venues and serves on the advisory boards of several pharmaceutical companies. Dr. Leonardi has been involved in more than 150 clinical trials and has published more than 150 original articles and abstracts in such journals as the Journal of the American Academy of Dermatology, the British Journal of Dermatology, Archives of Dermatology, the Journal of the American Medical Association, and the New England Journal of Medicine.

Kim Alexander Papp, MD, PhD, FRCPC

Canadian Dermatologist, Kim Alexander Papp, M.D., Ph.D., F.R.C.P.C. is the founder and President of Probity Medical Research, an organization that guides research physicians in the conduct of clinical research studies. Over the past 15 years Dr. Papp has conducted more than 170 clinical trials and followed over 2700 subjects in these studies. Dr. Papp has authored or co-authored more than 190 publications and abstracts on the results of his work. Dr. Papp has been an investigator in research studies on over 45 unique compounds in development for the treatment of Psoriasis. In addition to his passionate dedication to clinical research, Dr. Papp maintains a large, private medical dermatology practice where he follows thousands of psoriasis patients. Prior to his current positions, Dr. Papp taught at York University as well as the University of Waterloo. In his spare time, Dr. Papp trains and conducts seminars for other dermatologists around the world on new and developing therapies for dermatology. Dr. Papp is a Fellow of the Royal College of Physicians and Surgeons of Canada and a specialist in Dermatology. He received his Doctor of Medicine degree from the University of Calgary Medical School and survived his residency in Internal Medicine and Dermatology at the University of Toronto. Dr. Papp holds positions in both public and professional organizations including, Councilor for the International Psoriasis Council and Committee Representative for Dermatology at the Ontario Medical Association. He is also a member of several international organizations including the Canadian Dermatology Association, the European Academy of Dermatology and Venereology, the American Academy of Dermatology and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). He serves on numerous advisory boards and is a consultant for several pharmaceutical and biotech corporations.

Wingfield Rehmus, MD, MPH

Wingfield Rehmus, PhD, is a dermatologist living in Vancouver, British Columbia, Canada. Dr. Rehmus previously served as Assistant Director of Clinical Trials (2002-2004) and then Co-Director of Clinical Trials (2004-2006) at Stanford University’s Department of Dermatology. She also served as a member of the Stanford Administrative Panel on Human Research and the Stanford Clinical Research Scholarly Concentration Committee. Since leaving Stanford in 2006, Dr. Rehmus has worked for the Ministry of Health in the Republic of Palau as the Chair of the Strategic Planning Task Force.